These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3910488)

  • 21. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic mice.
    Bailey CJ; Flatt PR; Kwasowski P; Adams M
    Diabete Metab; 1986 Dec; 12(6):351-4. PubMed ID: 3545933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of serum glucose-dependent insulinotropic polypeptide as a novel risk factor for human colorectal adenoma.
    Sasaki Y; Takeda H; Sato T; Orii T; Fujishima S; Nagino K; Nishise S; Saito H; Tanaka Y; Kawata S
    Metabolism; 2011 Sep; 60(9):1253-8. PubMed ID: 21353263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects.
    Tappy L; Chiolero R; Randin JP; Burckhardt P; Felber JP
    Horm Metab Res; 1986 Dec; 18(12):821-6. PubMed ID: 3546047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
    Levitt NS; Vinik AI; Child PT
    J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls.
    Groop PH; Fyhrquist F; Groop LC
    Scand J Clin Lab Invest; 1985 Apr; 45(2):115-22. PubMed ID: 3890129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J; de Pierluissi R; de Martínez A
    Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
    Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
    J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats.
    Ebert R; Nauck M; Creutzfeldt W
    Horm Metab Res; 1991 Nov; 23(11):517-21. PubMed ID: 1816061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
    Ebert R; Creutzfeldt W
    Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R; Arnold R; Creutzfeldt W
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of insulin needs in insulin-dependent diabetics and healthy volunteers under fasting conditions.
    Beyer J; Krause U; Dobronz A; Fuchs B; Delver JR; Wagner R
    Horm Metab Res Suppl; 1990; 24():71-7. PubMed ID: 2272630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
    Sarson DL; Wood SM; Kansal PC; Bloom SR
    Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric inhibitory polypeptide (GIP) response in diabetes using a highly specific antiserum.
    Alam MJ; Kerr JI; Cormican K; Buchanan KD
    Diabet Med; 1992 Jul; 9(6):542-5. PubMed ID: 1643802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hepatic extraction of gastric inhibitory polypeptide and insulin.
    Hanks JB; Andersen DK; Wise JE; Putnam WS; Meyers WC; Jones RS
    Endocrinology; 1984 Sep; 115(3):1011-8. PubMed ID: 6378600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.
    Meier JJ; Nauck MA; Kask B; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
    World J Gastroenterol; 2006 Mar; 12(12):1874-80. PubMed ID: 16609993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased gastric inhibitory polypeptide is not reduced in patients with noninsulin-dependent diabetes mellitus treated with intense insulin therapy.
    Lardinois CK; Mazzaferri EL; Starich GH; Hollenbeck CB; Reaven GM
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1089-92. PubMed ID: 3902866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycemic (ob/ob) mice.
    Flatt PR; Kwasowski P; Howland RJ; Bailey CJ
    J Nutr; 1991 Jul; 121(7):1123-8. PubMed ID: 2051232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.